Video

Biosimilars in Specialty Pharmacy

Author(s):

Lauren Santye, Assistant Editor

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Monoclonal antibodies are used to treat lung cancer. They are created in a lab and designed to target specific proteins on cancer cells, stopping them from growing and dividing.
Gene therapy in lung cancer (LC) - isometric view 3d illustration
Related Content
Neuromuscular disorders neon glow nervous system visualizing diseases like ALS myasthenia gravis being treated advanced therapies under Neurology
September 9th 2025

Cemdisiran Monotherapy Improves Activities of Daily Living in Myasthenia Gravis

Luke Halpern, Assistant Editor
Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage
September 9th 2025

Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage

Jennifer Griffin, PharmD, MS Luke Halpern, Assistant Editor
Buprenorphine Rx medical pills in plastic bottle with tablets. Pills spilling out from yellow container. | Image Credit: luchschenF | stock.adobe.com
September 9th 2025

The Evolving Role of Retail Pharmacies in Expanding Buprenorphine Access

Danielle Valletti, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
September 9th 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
FDA approves 2 denosumab biosimilars, Bildyos and Bilprevda -- Image credit: gguy | stock.adobe.com
September 9th 2025

FDA Approves Bildyos and Bilprevda, Biosimilars of Reference Denosumab

Gillian McGovern, Associate Editor
Motor neuron connecting to muscle fiber, 3D illustration
September 9th 2025

Study: Apitegromab Meaningfully Improves Motor Function in Spinal Muscular Atrophy

Luke Halpern, Assistant Editor
© 2025 MJH Life Sciences

All rights reserved.